(Press Box) Frankfurt/Main, February 09, 2011, The company BioSciTec GmbH, the market leader for the automated assessment of diagnostic strip tests of all kinds undertakes cooperation with the company Mediwiss Analytic GmbH. The company Mediwiss GmbH are the worldwide leaders for in-vitro screening diagnostics and are now also using various assessment systems from the company BioSciTec in their product portfolio.

In a mutual development the company BioSciTec GmbH and the company Mediwiss Analytik GmbH have optimised the software controlled assessment of allergy test panels. Thanks to the new BLOTrix software generation B4C (BLOTrix 4 Cubos) and the new reading devices from BioSciTec the test strips are measured, assessed and archived with a high precision with up to 31 different assessment parameters. The simplification of the operation and speed of the measurement lead to a noticeable gain in efficiency and a substantially improved user acceptance.
„The quantification of multi-parameter tests on one blot or bio chip is currently one of the greatest challenges for hard and software solutions.“ says managing director Dr. Robert Jäger, BioSciTec GmbH and explains further: „What is mainly lacking is the standardisation of the measurements. Cross-device and cross-test repeatability of the measurements are the principal difficulty“. With the new products and solutions from BioSciTec these challenges can be overcome and the advantages of automated assessment such as standardisation, visualisation and archiving can be optimally utilised.

You will find further information about the cooperation between BioSciTec and Mediwiss Analytic on the Internet under: www.bioscitec.com and www.mediwiss-analytic.de.